Iterum Therapeutics (ITRM) Proxy Filing summary

Executive summary

• Extraordinary general meeting scheduled for February 18, 2026, with four proposals up for shareholder vote.

• Board of directors and a leading proxy advisory firm recommend voting in favor of all proposals.

• Voting is encouraged online or by phone, with a deadline of February 17, 2026, at 11:59 PM ET for remote participation.

Voting matters and shareholder proposals

• Four proposals are on the agenda for the extraordinary general meeting, as detailed in the definitive proxy statement.

• Shareholders are urged to vote regardless of the number of shares owned.

• Board and proxy advisor ISS both recommend voting FOR all proposals.

Board of directors and corporate governance

• Board of directors has taken a unified stance in recommending approval of all proposals.